Vor Biopharma (VOR) Capital Expenditures (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Capital Expenditures of $48000.0 for Q1 2026, down 84.71% quarter-over-quarter from $314000.0 in Q4 2025.
Vor Biopharma (VOR) Capital Expenditures (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Capital Expenditures for 7 consecutive years, with $48000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to $48000.0; the TTM figure through Mar 2026 stood at $989000.0 (up 760.0% YoY), while the FY2025 annual figure was $941000.0, up 310.92% from the prior year.
- Capital Expenditures slipped to $48000.0 in Q1 2026 per VOR's latest filing, from $314000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.8 million in Q2 2022 and bottomed at -$7.8 million in Q3 2022.
- Historically, Capital Expenditures has averaged $82875.0 across 5 years, with a median of $93000.0 in 2024.
- Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 4833.33% — and 2025, when it surged 4155.56%.
- Vor Biopharma's Capital Expenditures stood at -$18000.0 in 2022, then sank by 4833.33% to -$888000.0 in 2023, then soared by 108.11% to $72000.0 in 2024, then surged by 336.11% to $314000.0 in 2025, then sank by 84.71% to $48000.0 in 2026.
- Business Quant data shows VOR's Capital Expenditures at $48000.0 in Q1 2026, $314000.0 in Q4 2025, and $244000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120,000.00 |
| Jun 30, 2026 | 120,000.00 |
| Mar 31, 2026 | 48,000.00 |
| Mar 31, 2026 | 48,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Dec 31, 2025 | 314,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Sep 30, 2025 | 244,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Mar 31, 2024 | 114,000.00 |
| Dec 31, 2023 | -888,000.00 |
| Dec 31, 2023 | -888,000.00 |